Newborn Tablet 25 Units (Calydinogenase)

Adult dose

Administer 30~150I.U. orally in 3 divided doses daily. The dose may be adjusted appropriately according to age and symptoms.

This medication should not be used in patients with bleeding, such as immediately after a cerebral hemorrhage. Additionally, this medication contains lactose; therefore, patients with genetic conditions such as galactose intolerance, Lapp lactase deficiency, or glucose-galactose malabsorption should not take this medication. The medication contains a dye called Yellow No. 5; patients who have had allergies or hypersensitivity reactions to this component should use it with caution. Skin rashes or itching may occur during use, so if these symptoms appear, the medication should be discontinued immediately. Symptoms such as palpitations, gastrointestinal discomfort, nausea, vomiting, loss of appetite, abdominal pain, diarrhea, or constipation may occur. Additionally, symptoms such as fever, headache, drowsiness, or fatigue may rarely occur, so caution is advised. In elderly patients, physical function may be diminished, so the dosage should be reduced or used with increased caution.

• Rash
• itching
• palpitations
• abdominal discomfort
• nausea
• vomiting
• loss of appetite
• upper abdominal pain
• diarrhea
• constipation

This medication should be stored in a sealed container to prevent air and moisture from entering. It is also advisable to keep it in a cool, dry place away from direct sunlight.

Appearance

Crimson enteric-coated round tablet

Package unit

30 tablets/bottle, 100 tablets/bottle